Karyopharm Therapeutics
Doug Kinkade is a seasoned professional in the pharmaceutical industry, currently serving as the Senior Corporate Account Director at Karyopharm Therapeutics Inc. since January 2021. Prior experience includes roles such as Regional Marketing Manager at Rigel Pharmaceuticals Inc. and various positions at Exelixis, including Strategic Accounts, Senior Regional Account Manager, and Oncology Sales Specialist. Doug also contributed to Onyx Pharmaceuticals and Novartis as a sales specialist, focusing on oncology, and started a successful career at TAP Pharmaceuticals as a Senior Sales Specialist. Doug holds a degree in Communications and Marketing from Indiana State University, achieved between 1989 and 1994.
This person is not in any teams
This person is not in any offices
Karyopharm Therapeutics
13 followers
Karyopharm Therapeutics Inc. (Nasdaq: KPTI) is an innovation-driven pharmaceutical company dedicated to the discovery, development, and commercialization of novel first-in-class drugs directed against nuclear export and related targets for the treatment of cancer and other major diseases. Karyopharm's Selective Inhibitor of Nuclear Export (SINE) compounds function by binding with and inhibiting the nuclear export protein XPO1 (or CRM1).